The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation
Abstract
BACKGROUND: In 2009, the U.S. Preventive Services Task Force recommended biennial mammography screening for women aged 50 to 74 years and selective screening for those aged 40 to 49 years. PURPOSE: To review studies of the effectiveness of breast cancer screening in average-risk women. DATA SOURCES: MEDLINE and Cochrane databases to 4 June 2015. STUDY SELECTION: English-language randomized, controlled trials and observational studies of screening with mammography, magnetic resonance imaging, and ultrasonography that reported breast cancer mortality, all-cause mortality, or advanced breast cancer outcomes. DATA EXTRACTION: Investigators extracted and confirmed data and dual rated study quality; discrepancies were resolved through consensus. DATA SYNTHESIS: Fair-quality evidence from a meta-analysis of mammography trials indicated relative risks (RRs) for breast cancer mortality of 0.92 for women aged 39 to 49 years (95% CI, 0.75 to 1.02) (9 trials; 3 deaths prevented per 10,000 women over 10 years); 0.86 for those aged 50 to 59 years (CI, 0.68 to 0.97) (7 trials; 8 deaths prevented per 10,000 women over 10 years); 0.67 for those aged 60 to 69 years (CI, 0.54 to 0.83) (5 trials; 21 deaths prevented per 10,000 women over 10 years); and 0.80 for those aged 70 to 74 years (CI, 0.51 to 1.28) (3 trials; 13 deaths prevented per 10,000 women over 10 years). Risk reduction was 25% to 31% for women aged 50 to 69 years in observational studies of mammography screening. All-cause mortality was not reduced with screening. Advanced breast cancer was reduced for women aged 50 years or older (RR, 0.62 [CI, 0.46 to 0.83]) (3 trials) but not those aged 39 to 49 years (RR, 0.98 [CI, 0.74 to 1.37]) (4 trials); less evidence supported this outcome. LIMITATIONS: Most trials used imaging technologies and treatments that are now outdated, and definitions of advanced breast cancer were heterogeneous. Studies of effectiveness based on risk factors, intervals, or other modalities were unavailable or methodologically limited. CONCLUSION: Breast cancer mortality is generally reduced with mammography screening, although estimates are not statistically significant at all ages and the magnitudes of effect are small. Advanced cancer is reduced with screening for women aged 50 years or older. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Current methods of the U.S. Preventive Services Task Force
Harris, R. P., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., Teutsch, S. M., & Atkins, D. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00261-6 · Cited by 1,731
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206809 · Cited by 1,367
Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00009 · Cited by 1,248
Self-citationLong-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Skaane, P., Bandos, A. I., Gullien, R., Eben, E. B., Ekseth, U., Haakenaasen, U., Izadi, M., Jebsen, I. N., Jahr, G., Krager, M., et al. (2013) · Radiology · doi:10.1148/radiol.12121373 · Cited by 1,012
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson, I., Aspegren, K., Janzon, L., Landberg, T., Lindholm, K., Linell, F., Ljungberg, O., Ranstam, J., & Sigfússon, B. (1988) · BMJ · doi:10.1136/bmj.297.6654.943 · Cited by 916
Miller, A. B., Baines, C. J., To, T. M., & Wall, C. (1992) · Europe PMC (PubMed Central) · Cited by 864
Ten- to Fourteen-Year Effect of Screening on Breast Cancer Mortality 2
(1982) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/69.2.349 · Cited by 840
Tabár, L., Vitak, B., Chen, T. H.-H., Yen, A. M.-F., Cohen, A., Tot, T., Chiu, S. Y.-H., Chen, S. L.-S., Fann, J. C.-Y., Rosell, J., et al. (2011) · Radiology · doi:10.1148/radiol.11110469 · Cited by 791
Miller, A. B., Wall, C., Baines, C. J., Sun, P., To, T., & Narod, S. A. (2014) · BMJ · doi:10.1136/bmj.g366 · Cited by 702
Efficacy of breast cancer screening by age. New results swedish two-county trial
Tabar, L., Fagerberg, G., Chen, H.-H., Duffy, S. W., Smart, C. R., Gad, A., & Smith, R. A. (1995) · Cancer · doi:10.1002/1097-0142(19950515)75:10<2507::aid-cncr2820751017>3.0.co;2-h · Cited by 557
Effect of Screening Mammography on Breast-Cancer Mortality in Norway
Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000727 · Cited by 526
A LIKELIHOOD APPROACH TO META-ANALYSIS WITH RANDOM EFFECTS
HARDY, R. J., & THOMPSON, S. G. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960330)15:6<619::aid-sim188>3.0.co;2-a · Cited by 522
Miller, A. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1490 · Cited by 512
Moss, S. M., Cuckle, H., Evans, A., Johns, L., Waller, M., & Bobrow, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69834-6 · Cited by 503
Broeders, M., Moss, S., Nyström, L., Njor, S., Jonsson, H., Paap, E., Massat, N., Duffy, S., Lynge, E., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012078 · Cited by 489
THE SWEDISH TWO-COUNTY TRIAL TWENTY YEARS LATER
Tabár, L., Vitak, B., Chen, H.-H., Duffy, S. W., Yen, M.-F., Chiang, C.-F., Krusemo, U. B., Tot, T., & Smith, R. A. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70191-3 · Cited by 460
Risk Factors for Breast Cancer for Women Aged 40 to 49 Years: A Systematic Review and Meta-analysis
Nelson, H. D., Zakher, B., Cantor, A., Fu, R., Griffin, J., O'Meara, E. S., Buist, D. S. M., Kerlikowske, K., van Ravesteyn, N. T., Trentham-Dietz, A., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-9-201205010-00006 · Cited by 425
Self-citationHubbard, R. A., Kerlikowske, K., Flowers, C. I., Yankaskas, B. C., Zhu, W., & Miglioretti, D. L. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00004 · Cited by 414
Miller, A. B., To, T., Baines, C. J., & Wall, C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00005 · Cited by 394
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening
Alexander, F., Anderson, T., Brown, H., Forrest, A., Hepburn, W., Kirkpatrick, A., Muir, B., Prescott, R., & Smith, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07413-3 · Cited by 388
Otto, S. J., Fracheboud, J., Looman, C. W., Broeders, M. J., Boer, R., Hendriks, J. H., Verbeek, A. L., & de Koning, H. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13132-7 · Cited by 333
Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational Study
Rose, S. L., Tidwell, A. L., Bujnoch, L. J., Kushwaha, A. C., Nordmann, A. S., & Sexton, R. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9672 · Cited by 329
The Gothenburg Breast Screening Trial
Bjurstam, N., Björneld, L., Warwick, J., Sala, E., Duffy, S. W., Nyström, L., Walker, N., Cahlin, E., Eriksson, O., Hafström, L., et al. (2003) · Cancer · doi:10.1002/cncr.11361 · Cited by 308
Chu, K. C., Smart, C. R., & Tarone, R. E. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.14.1125 · Cited by 302
Autier, P., Boniol, M., Gavin, A., & Vatten, L. J. (2011) · BMJ · doi:10.1136/bmj.d4411 · Cited by 300
Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer
Coldman, A., Phillips, N., Wilson, C., Decker, K., Chiarelli, A. M., Brisson, J., Zhang, B., Payne, J., Doyle, G., & Ahmad, R. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju261 · Cited by 295
The Swedish Organised Service Screening Evaluation Group (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0349 · Cited by 258
Randomized study of mammography screening — preliminary report on mortality in the stockholm trial
Frisell, J., Eklund, G., Hellström, L., Lidbrink, E., Rutqvist, L. E., & Somell, A. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01975443 · Cited by 258
Hellquist, B. N., Duffy, S. W., Abdsaleh, S., Björneld, L., Bordás, P., Tabár, L., Viták, B., Zackrisson, S., Nyström, L., & Jonsson, H. (2011) · Cancer · doi:10.1002/cncr.25650 · Cited by 254
Andersson, I., & Janzon, L. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.63 · Cited by 250
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2013) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3182978e4a · Cited by 244
Duffy, S. W., Tabar, L., Olsen, A. H., Vitak, B., Allgood, P. C., Chen, T. H. H., Yen, A. M. F., & Smith, R. A. (2010) · Journal of Medical Screening · doi:10.1258/jms.2009.009094 · Cited by 240
Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial
Frisell, J., Lidbrink, E., Hellström, L., & Rutqvist, L.-E. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005872617944 · Cited by 223
Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy
Kerlikowske, K., Zhu, W., Hubbard, R. A., Geller, B., Dittus, K., Braithwaite, D., Wernli, K. J., Miglioretti, D. L., O’Meara, E. S., & Breast Cancer Surveillance Consortium, F. T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.307 · Cited by 209
Njor, S., Nyström, L., Moss, S., Paci, E., Broeders, M., Segnan, N., & Lynge, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012080 · Cited by 185
Hakama, M., Pukkala, E., HeikkilÄ, M., & Kallio, M. (1997) · BMJ · doi:10.1136/bmj.314.7084.864 · Cited by 161
Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
Hofvind, S. S. H., Ursin, G., Tretli, S., Sebuødegård, S., & Møller, B. (2013) · Cancer · doi:10.1002/cncr.28174 · Cited by 134
Autier, P., Héry, C., Haukka, J. K., Boniol, M., & Byrnes, G. B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7041 · Cited by 128
Advanced breast cancer incidence following population-based mammographic screening
Autier, P., Boniol, M., Middleton, R., Doré, J., Héry, C., Zheng, T., & Gavin, A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq633 · Cited by 126
Independent Prognostic Value of Screen Detection in Invasive Breast Cancer
Mook, S., Veer, L. V. ‘., Rutgers, E. J. T., Ravdin, P. M., van de Velde, A. O., van Leeuwen, F. E., Visser, O. J., & Schmidt, M. K. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr043 · Cited by 113
Biennial Versus Annual Mammography and the Risk of Late-Stage Breast Cancer
White, E. E., Miglioretti, D. L., Yankaskas, B. C., Geller, B. M., Rosenberg, R. D., Kerlikowske, K. M., Saba, L. M., Vacek, P. M., Carney, P. A., Buist, D. S. M., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh337 · Cited by 106
Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction
the IMPACT Working Group, Puliti, D., Miccinesi, G., Collina, N., Lisi, V. D., Federico, M., Ferretti, S., Finarelli, A. C., Foca, F., Mangone, L., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604532 · Cited by 85
The Gothenburg Breast Screening Trial
Bjurstam, N., Björneld, L., Duffy, S. W., Smith, T. C., Cahlin, E., Eriksson, O., Hafström, L., Lingaas, H., Mattsson, J., Persson, S., et al. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199803000-00016 · Cited by 81
The frequency of breast cancer screening
(2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00397-5 · Cited by 78
An Analysis of the Mortality Effect in a Breast Cancer Screening Study
Aron, J. L., & Prorok, P. C. (1986) · International Journal of Epidemiology · doi:10.1093/ije/15.1.36 · Cited by 74
Tabár, L. K., Chen, H.-H., Fagerberg, G., Duffy, S. W., & Smith, T. C. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.43 · Cited by 72
Breast cancer screening for women ages 50 to 69years a systematic review of observational evidence
Harris, R., Yeatts, J., & Kinsinger, L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.07.004 · Cited by 57
Weighing the Benefits and Burdens of Mammography Screening Among Women Age 80 Years or Older
Schonberg, M. A., Silliman, R. A., & Marcantonio, E. R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9877 · Cited by 46
Block, L. D., Jarlenski, M., Wu, A. W., & Bennett, W. L. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2482-5 · Cited by 45
Mammographic breast cancer screening —a randomized trial in Malmö, Sweden
Andersson, I., Janzon, L., & Sigfússon, B. F. (1985) · Maturitas · doi:10.1016/0378-5122(85)90031-3 · Cited by 39
Trends in Breast Cancer Mortality in Sweden before and after Implementation of Mammography Screening
Haukka, J. K., Byrnes, G. B., Boniol, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022422 · Cited by 33
Lousdal, M. L., Kristiansen, I. S., Møller, B., & Støvring, H. (2014) · European Journal of Public Health · doi:10.1093/eurpub/cku015 · Cited by 31
Nelson, H. D., Weerasinghe, R. K., Wang, L., & Grunkemeier, G. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131903 · Cited by 24
Self-citationThe association between the pre-diagnosis mammography screening interval and advanced breast cancer
Goel, A., Littenberg, B., & Burack, R. C. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9334-5 · Cited by 20
Impact of Mammography Screening Interval on Breast Cancer Diagnosis by Menopausal Status and BMI
Dittus, K. L., Geller, B. M., Weaver, D. L., Kerlikowske, K. M., Zhu, W., Hubbard, R. A., Braithwaite, D., O’Meara, E. S., & Miglioretti, D. L. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2507-0 · Cited by 19
Screening for Breast Cancer With Digital Breast Tomosynthesis
Melnikow, J. A., Fenton, J. J., Miglioretti, D. L., Whitlock, E. P., & Weyrich, M. S. (2016) · Europe PMC (PubMed Central) · Cited by 11
Olsson, Å., Garne, J. P., Tengrup, I., Zackrisson, S., & Manjer, J. (2009) · Cancer Epidemiology · doi:10.1016/j.canep.2009.04.008 · Cited by 8
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(19980701)83:1 · Cited by 3
Cited by
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Liquid biopsy enters the clinic — implementation issues and future challenges
Ignatiadis, M., Sledge, G. W., & Jeffrey, S. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00457-x · Cited by 1,191
Circulating tumor DNA and liquid biopsy in oncology
Cescon, D. W., Bratman, S. V., Chan, S. M., & Siu, L. L. (2020) · Nature Cancer · doi:10.1038/s43018-020-0043-5 · Cited by 600
Metadata
- Authors
- Nelson, H. D., Fu, R., Cantor, A., Pappas, M., Daeges, M., & Humphrey, L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2016-02-16
- Volume
- 164
- Issue
- 4
- Pages
- 244-255
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2235624370
- Cited by
- 611
- References
- 64
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.